Transcriptomics

Dataset Information

0

Gene Expression in Frontal Cortex in Major Depression and HIV


ABSTRACT: Major depressive disorder (MDD) is a clinically defined entity with little understanding as to the underlying pathological substrate. Biologically, MDD is characterized by disruption of neurotransmitters, especially serotonin and noradrenaline, which are the main targets of antidepressants. We previously demonstrated significant reduction of glial cell number in the cingulate and dorsolateral prefrontal cortical regions. Unfortunately, individuals living with HIV still have very high rates of MDD, despite the fact that mortality rates have fallen sharply with effective antiretroviral treatment. It is possible that in this treatment era, living with chronic HIV infection may result in long-term neuropathological changes that predispose to MDD. For example, it is known that HIV is associated with a range of inflammatory pathologies, neuronal loss, and dendrite-synaptic damage. In HIV, these neurodegenerative changes have been linked to neurocognitive impairments, however it is also possible that these changes potentiate MDD. In the current study, we sought to determine whether there are changes in gene expression in the MDD brain in the frontal cortex in HIV-context. We identify a large number of genes dysregulated at p<0.05 significance.

ORGANISM(S): Homo sapiens

PROVIDER: GSE17440 | GEO | 2010/02/01

SECONDARY ACCESSION(S): PRJNA123617

REPOSITORIES: GEO

Dataset's files

Source:
Action DRS
Other
Items per page:
1 - 1 of 1

Similar Datasets

2010-02-01 | E-GEOD-17440 | biostudies-arrayexpress
2018-08-01 | GSE87620 | GEO
2010-02-01 | GSE17486 | GEO
2023-08-07 | GSE216103 | GEO
2023-08-07 | GSE216102 | GEO
2022-03-21 | GSE190518 | GEO
2018-09-06 | GSE119482 | GEO
2021-02-26 | E-MTAB-8891 | biostudies-arrayexpress
2017-03-30 | GSE97154 | GEO
2023-12-31 | GSE217795 | GEO